When analyzing different breast cancer molecular subtypes (normal-like, luminal A, luminal B, ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2), and basal), ERBB2 and basal tumors show significantly lower FBXW7 expression compared to normal-like tumors [149]. This evidence concerns the gene ERBB2 and breast cancer.